Background: The diagnosis of pediatric-onset inflammatory bowel disease (PIBD) can be
challenging in choosing the most informative diagnostic tests and correctly classifying PIBD …

Objective We aimed to provide an evidence-supported update of the ECCO-ESPGHAN
guideline on the medical management of paediatric Crohn’s disease [CD]. Methods We formed …

Identifying subjects with cystic fibrosis (CF) who may benefit from cystic fibrosis transmembrane
conductance regulator (CFTR)–modulating drugs is time-consuming, costly, and …

Intact interleukin-10 receptor (IL-10R) signaling on effector and T regulatory (Treg) cells are
each independently required to maintain immune tolerance. Here we show that IL-10 …

Methods: A group of 27 experts in pediatric IBD participated in an iterative consensus
process including 2 face-to-face meetings, following an open call to ESPGHAN and ECCO …

BACKGROUND & AIMS: We evaluated the efficacy and safety of infliximab for inducing and
maintaining benefit in children with moderately to severely active ulcerative colitis (UC). …

About 10–15% of patients with inflammatory bowel disease are diagnosed before the age of
18 years. 121 During puberty the incidence is 7 per 100 000 per year and increases further …

OBJECTIVES: Acute severe ulcerative colitis (ASC) is a potentially life-threatening disease.
We aimed to formulate guidelines for managing ASC in children based on systematic review …

Methods: A group of 20 experts in pediatric IBD participated in an iterative consensus process
including 2 face-to-face meetings, following an open call to Nutrition Committee of the …

Background It has been speculated that pediatric Crohn's disease (CD) is a distinct disease
entity, with probably different disease subtypes. We therefore aimed to accurately phenotype …